|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
36,010,000 |
Market
Cap: |
581.20(M) |
Last
Volume: |
129,261 |
Avg
Vol: |
128,156 |
52
Week Range: |
$9.69 - $17.49 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
7,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$101,025 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
0 |
12,505 |
Total Sell Value |
$0 |
$0 |
$0 |
$232,268 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-06-20 |
2024-03-19 |
2023-09-19 |
2022-09-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burzik Catherine M |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,976 |
5,976 |
|
- |
|
Hannon Jason |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
9,431 |
|
- |
|
Kenny Kevin J |
President of Global Spine |
|
2020-12-04 |
4 |
D |
$37.09 |
$36,497 |
D/D |
(984) |
18,792 |
|
- |
|
Serbousek Jon Carl |
CEO |
|
2020-11-01 |
4 |
D |
$31.26 |
$45,827 |
D/D |
(1,466) |
74,181 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2020-09-26 |
4 |
D |
$29.40 |
$16,170 |
D/D |
(550) |
35,965 |
|
- |
|
Gonsalves Paul |
President, Global Extremities |
|
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,624 |
10,624 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2020-09-05 |
4 |
D |
$28.79 |
$10,508 |
D/D |
(365) |
36,515 |
|
- |
|
Serbousek Jon Carl |
CEO |
|
2020-08-07 |
4 |
D |
$33.24 |
$29,816 |
D/D |
(897) |
75,647 |
|
- |
|
Doug Rice |
CFO |
|
2020-07-08 |
4 |
D |
$30.34 |
$44,175 |
D/D |
(1,456) |
55,706 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Admin Officer |
|
2020-07-03 |
4 |
D |
$32.19 |
$11,138 |
D/D |
(346) |
36,880 |
|
- |
|
Doug Rice |
CFO |
|
2020-07-03 |
4 |
D |
$32.19 |
$12,007 |
D/D |
(373) |
57,162 |
|
- |
|
Finegan Michael |
Chief Strategy Officer |
|
2020-07-03 |
4 |
D |
$32.19 |
$11,685 |
D/D |
(363) |
47,175 |
|
- |
|
Doug Rice |
CFO |
|
2020-07-01 |
4 |
D |
$32.34 |
$12,192 |
D/D |
(377) |
57,535 |
|
- |
|
Finegan Michael |
Chief Strategy Officer |
|
2020-07-01 |
4 |
D |
$32.34 |
$12,774 |
D/D |
(395) |
47,538 |
|
- |
|
Sicard John |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
10,919 |
|
- |
|
Sainz Maria |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
40,871 |
|
- |
|
Marks Lilly |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
25,794 |
|
- |
|
Matricaria Ronald A |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,520 |
164,122 |
|
- |
|
Lukianov Alexis V |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
16,083 |
|
- |
|
Hinrichs James F. |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
50,514 |
|
- |
|
Hannon Jason |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
4,588 |
|
- |
|
Paolucci Michael E |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
19,779 |
|
- |
|
Finegan Michael |
Chief Strategy Officer |
|
2020-06-05 |
4 |
S |
$37.41 |
$327,323 |
D/D |
(8,750) |
47,933 |
|
- |
|
Finegan Michael |
Chief Strategy Officer |
|
2020-06-05 |
4 |
OE |
$21.78 |
$190,575 |
D/D |
8,750 |
56,683 |
|
- |
|
Finegan Michael |
Chief Strategy Officer |
|
2020-04-02 |
4 |
D |
$26.66 |
$8,505 |
D/D |
(319) |
47,933 |
|
- |
|
362 Records found
|
|
Page 6 of 15 |
|
|